Similar articles for PMID: 27023463

Year	Number of Results
1990	1
1991	1
1996	1
1997	3
1998	1
1999	4
2000	2
2001	7
2002	8
2003	8
2004	8
2005	8
2006	8
2007	15
2008	11
2009	8
2010	13
2011	10
2012	8
2013	14
2014	10
2015	8
2016	21
2017	26
2018	29
2019	21
2020	13
2021	25
2022	18
2023	6
2024	1

1

Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.

Niedrig D, Maechler S, Hoppe L, Corti N, Kovari H, Russmann S. Niedrig D, et al. Eur J Clin Pharmacol. 2016 Jul;72(7):859-67. doi: 10.1007/s00228-016-2043-z. Epub 2016 Mar 29. Eur J Clin Pharmacol. 2016. PMID: 27023463

2

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W. Milberg P, et al. J Pharmacol Exp Ther. 2002 Oct;303(1):218-25. doi: 10.1124/jpet.102.037911. J Pharmacol Exp Ther. 2002. PMID: 12235254

3

Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.

Khan Q, Ismail M, Khan S. Khan Q, et al. BMC Pharmacol Toxicol. 2017 Dec 1;18(1):75. doi: 10.1186/s40360-017-0181-2. BMC Pharmacol Toxicol. 2017. PMID: 29191244 Free PMC article.

4

Prevalence of the risk factors for QT prolongation and associated drug-drug interactions in a cohort of medical inpatients.

Khan Q, Ismail M, Haider I, Ali Z. Khan Q, et al. J Formos Med Assoc. 2019 Jan;118(1 Pt 1):109-115. doi: 10.1016/j.jfma.2018.01.016. Epub 2018 Feb 17. J Formos Med Assoc. 2019. PMID: 29458991 Free article.

5

Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Jackobson G, Carmel NN, Lotan D, Kremer A, Justo D. Jackobson G, et al. Z Gerontol Geriatr. 2018 Jan;51(1):41-47. doi: 10.1007/s00391-016-1155-5. Epub 2016 Nov 22. Z Gerontol Geriatr. 2018. PMID: 27878411 Review. English.

6

Drug-induced torsades de pointes in patients aged 80 years or more.

Paran Y, Mashav N, Henis O, Swartzon M, Arbel Y, Justo D. Paran Y, et al. Anadolu Kardiyol Derg. 2008 Aug;8(4):260-5. Anadolu Kardiyol Derg. 2008. PMID: 18676301 Review.

7

Drug-induced QT prolongation and sudden death.

Del Rosario ME, Weachter R, Flaker GC. Del Rosario ME, et al. Mo Med. 2010 Jan-Feb;107(1):53-8. Mo Med. 2010. PMID: 20222297 Free PMC article. Review.

8

Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.

Das B, Rawat VS, Ramasubbu SK, Kumar B. Das B, et al. Therapie. 2019 Dec;74(6):599-609. doi: 10.1016/j.therap.2019.03.008. Epub 2019 Apr 4. Therapie. 2019. PMID: 31053339

9

QT prolongation with antimicrobial agents: understanding the significance.

Owens RC Jr. Owens RC Jr. Drugs. 2004;64(10):1091-124. doi: 10.2165/00003495-200464100-00005. Drugs. 2004. PMID: 15139788 Review.

10

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.

De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N. De Ponti F, et al. Drug Saf. 2002;25(4):263-86. doi: 10.2165/00002018-200225040-00004. Drug Saf. 2002. PMID: 11994029 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

278 results

Results by year